Cure of multidrug-resistant Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin
- PMID: 15764204
- DOI: 10.1080/00365540410020776
Cure of multidrug-resistant Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin
Abstract
Continuous intravenous colistin (2,000,000 units per 24 h) was administered in a 41-y-old patient with Acinetobacter baumannii bacteraemia, which led to the cure of the infection. The isolated microorganism was a multi-resistant strain (it was sensitive only to colistin). In addition, the patient had developed allergic reactions to previously administered antimicrobial agents of several classes during his hospitalization. Continuous intravenous infusion of colistin proved to be a salvage regimen, which led to cure of a bacteraemia due to a multi-resistant isolate, without showing any allergic cross-reactivity with other antibiotics.
Similar articles
-
Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin.Saudi Med J. 2005 Apr;26(4):656-8. Saudi Med J. 2005. PMID: 15900379
-
Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units.Eur J Cardiothorac Surg. 2008 Jun;33(6):1086-90. doi: 10.1016/j.ejcts.2008.02.012. Epub 2008 Mar 14. Eur J Cardiothorac Surg. 2008. PMID: 18339553
-
Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin.J Microbiol Immunol Infect. 2007 Dec;40(6):537-40. J Microbiol Immunol Infect. 2007. PMID: 18087636
-
Therapeutic options for Acinetobacter baumannii infections.Expert Opin Pharmacother. 2008 Mar;9(4):587-99. doi: 10.1517/14656566.9.4.587. Expert Opin Pharmacother. 2008. PMID: 18312160 Review.
-
Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia.Clin Infect Dis. 2006 Sep 1;43 Suppl 2:S89-94. doi: 10.1086/504485. Clin Infect Dis. 2006. PMID: 16894521 Review.
Cited by
-
Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action.Antimicrob Agents Chemother. 2006 Apr;50(4):1251-6. doi: 10.1128/AAC.50.4.1251-1256.2006. Antimicrob Agents Chemother. 2006. PMID: 16569836 Free PMC article.
-
Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration.Antimicrob Agents Chemother. 2005 Nov;49(11):4814-5. doi: 10.1128/AAC.49.11.4814-4815.2005. Antimicrob Agents Chemother. 2005. PMID: 16251342 Free PMC article. No abstract available.
-
Challenges of Colistin Use in ICU and Therapeutic Drug Monitoring: A Literature Review.Antibiotics (Basel). 2023 Feb 22;12(3):437. doi: 10.3390/antibiotics12030437. Antibiotics (Basel). 2023. PMID: 36978303 Free PMC article. Review.
-
Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model.Antimicrob Agents Chemother. 2011 Dec;55(12):5685-95. doi: 10.1128/AAC.05298-11. Epub 2011 Sep 12. Antimicrob Agents Chemother. 2011. PMID: 21911563 Free PMC article.
-
Colistin: the phoenix arises.Can J Infect Dis Med Microbiol. 2006 Sep;17(5):267-9. doi: 10.1155/2006/901873. Can J Infect Dis Med Microbiol. 2006. PMID: 18382637 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical